Complete financial analysis of Dongwha Pharm.Co.,Ltd (000020.KS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Dongwha Pharm.Co.,Ltd, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- BT Group plc (BTGOF) Income Statement Analysis – Financial Results
- Hayashikane Sangyo Co.,Ltd. (2286.T) Income Statement Analysis – Financial Results
- LULULEMON CDR (CAD HEDGED) (LULU.NE) Income Statement Analysis – Financial Results
- Convertidora Industrial, S.A.B. de C.V. (CONVERA.MX) Income Statement Analysis – Financial Results
- CIM Real Estate Finance Trust, Inc. (CMRF) Income Statement Analysis – Financial Results
Dongwha Pharm.Co.,Ltd (000020.KS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.dong-wha.co.kr
About Dongwha Pharm.Co.,Ltd
Dongwha Pharm Co., Ltd. manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxant/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and teeth, hepatic protector, nutrient, tonic, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health subsidiary foods; foods and drinks; and cosmetics. The company was founded in 1897 and is based in Seoul, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 361.11B | 340.43B | 293.02B | 272.08B | 307.15B | 306.60B | 258.88B | 237.47B | 223.20B | 213.47B | 220.24B | 223.37B | 234.56B | 215.28B | 145.12B | 188.61B | 175.12B | 148.74B |
| Cost of Revenue | 170.69B | 159.44B | 143.67B | 133.41B | 185.42B | 190.70B | 150.80B | 134.29B | 126.62B | 118.27B | 124.57B | 124.60B | 126.63B | 121.48B | 79.60B | 83.43B | 77.65B | 76.04B |
| Gross Profit | 190.42B | 180.99B | 149.35B | 138.67B | 121.73B | 115.90B | 108.08B | 103.18B | 96.58B | 95.20B | 95.67B | 98.77B | 107.93B | 93.80B | 65.52B | 105.18B | 97.47B | 72.69B |
| Gross Profit Ratio | 52.73% | 53.17% | 50.97% | 50.97% | 39.63% | 37.80% | 41.75% | 43.45% | 43.27% | 44.60% | 43.44% | 44.22% | 46.01% | 43.57% | 45.15% | 55.77% | 55.66% | 48.87% |
| Research & Development | 21.55B | 19.28B | 17.34B | 16.91B | 16.26B | 15.60B | 14.08B | 13.72B | 13.33B | 11.77B | 1.36B | 851.30M | 1.08B | 66.24M | 248.41M | 311.19M | 1.40B | 440.70M |
| General & Administrative | 66.02B | 10.88B | 9.00B | 8.39B | 8.59B | 8.41B | 8.16B | 7.17B | 7.95B | 7.73B | 7.46B | 6.52B | 6.29B | 6.43B | 4.82B | 5.70B | 4.32B | 4.17B |
| Selling & Marketing | 77.55B | 65.74B | 47.42B | 42.44B | 40.86B | 39.87B | 37.42B | 35.01B | 35.16B | 32.99B | 43.45B | 37.99B | 34.04B | 34.23B | 19.84B | 24.94B | 28.56B | 22.42B |
| SG&A | 143.57B | 76.62B | 56.41B | 50.83B | 49.45B | 48.28B | 45.58B | 42.18B | 43.11B | 40.72B | 50.91B | 44.50B | 40.34B | 40.66B | 24.66B | 30.64B | 32.88B | 26.59B |
| Other Expenses | 0.00 | 55.17B | 53.10B | 47.77B | 46.10B | 400.75M | -1.67B | 21.73B | 133.78M | -2.80B | -2.30B | -2.31B | -5.68B | -4.51B | -2.11B | -3.05B | -4.62B | -3.07B |
| Operating Expenses | 165.11B | 151.08B | 126.85B | 115.51B | 111.81B | 104.67B | 97.10B | 91.92B | 91.77B | 87.41B | 93.61B | 88.77B | 82.31B | 83.48B | 53.13B | 65.22B | 63.92B | 58.52B |
| Cost & Expenses | 342.33B | 310.51B | 270.52B | 248.92B | 297.23B | 295.37B | 247.89B | 226.21B | 218.39B | 205.68B | 218.18B | 213.37B | 208.94B | 204.96B | 132.73B | 148.64B | 141.57B | 134.57B |
| Interest Income | 3.25B | 2.39B | 1.07B | 1.84B | 1.94B | 2.17B | 1.17B | 856.90M | 786.12M | 896.38M | 926.21M | 1.38B | 669.89M | 989.47M | 1.01B | 3.65B | 4.06B | 2.83B |
| Interest Expense | 308.01M | 370.00M | 383.11M | 292.15M | 206.96M | 0.00 | 250.00 | 7.71M | 136.69M | 231.60M | 384.34M | 1.06B | 1.76B | 2.45B | 1.30B | 347.28M | 447.73M | 624.76M |
| Depreciation & Amortization | 13.90B | 12.51B | 12.09B | 10.71B | 11.48B | 11.36B | 11.50B | 12.16B | 11.86B | 12.64B | 12.53B | 12.20B | 12.46B | 18.73B | 15.23B | 3.51B | 3.47B | 3.32B |
| EBITDA | 48.74B | 38.23B | 39.41B | 44.75B | 28.34B | 25.90B | 76.72B | 47.37B | 18.00B | 18.27B | 13.81B | 21.69B | 33.25B | 26.61B | 28.51B | 45.32B | 36.79B | 17.46B |
| EBITDA Ratio | 13.50% | 12.89% | 12.78% | 12.95% | 9.30% | 7.24% | -12.37% | 19.44% | 8.06% | 8.69% | 6.26% | 9.75% | 14.25% | 11.99% | 18.46% | 23.57% | 20.80% | 11.71% |
| Operating Income | 25.30B | 29.92B | 22.50B | 23.15B | 17.09B | 11.23B | 10.99B | 11.26B | 4.81B | 7.79B | 2.06B | 10.00B | 25.62B | 10.32B | 12.39B | 39.96B | 33.54B | 14.17B |
| Operating Income Ratio | 7.01% | 8.79% | 7.68% | 8.51% | 5.57% | 3.66% | 4.24% | 4.74% | 2.16% | 3.65% | 0.94% | 4.48% | 10.92% | 4.79% | 8.54% | 21.19% | 19.16% | 9.53% |
| Total Other Income/Expenses | 11.65B | -6.83B | -2.27B | 4.44B | -854.10M | 3.31B | 54.23B | 24.40B | 1.19B | 62.16M | -1.17B | -1.57B | -6.59B | -4.89B | -412.61M | 1.50B | -673.69M | -651.46M |
| Income Before Tax | 36.96B | 23.09B | 26.53B | 33.64B | 16.61B | 14.54B | 65.22B | 35.66B | 6.00B | 5.40B | 889.90M | 8.43B | 19.03B | 5.43B | 11.98B | 41.46B | 32.87B | 13.52B |
| Income Before Tax Ratio | 10.23% | 6.78% | 9.05% | 12.36% | 5.41% | 4.74% | 25.19% | 15.01% | 2.69% | 2.53% | 0.40% | 3.77% | 8.11% | 2.52% | 8.25% | 21.98% | 18.77% | 9.09% |
| Income Tax Expense | 8.72B | 1.49B | 6.94B | 4.92B | 7.21B | 4.47B | 18.21B | 9.40B | 391.97M | 464.74M | -121.96M | 7.12B | 1.35B | 2.99M | 5.26B | 12.94B | 11.38B | 5.45B |
| Net Income | 27.44B | 20.38B | 17.87B | 28.51B | 9.40B | 10.07B | 47.01B | 26.25B | 5.61B | 4.94B | 1.01B | 1.31B | 17.68B | 5.43B | 6.72B | 28.52B | 21.50B | 8.07B |
| Net Income Ratio | 7.60% | 5.99% | 6.10% | 10.48% | 3.06% | 3.28% | 18.16% | 11.06% | 2.51% | 2.31% | 0.46% | 0.59% | 7.54% | 2.52% | 4.63% | 15.12% | 12.27% | 5.42% |
| EPS | 991.07 | 736.42 | 646.68 | 1.03K | 330.20 | 365.00 | 1.70K | 949.00 | 202.00 | 177.00 | 36.00 | 47.00 | 633.00 | 194.00 | 240.00 | 1.02K | 769.60 | 288.80 |
| EPS Diluted | 991.07 | 736.42 | 646.68 | 1.03K | 330.20 | 365.00 | 1.70K | 949.00 | 202.00 | 177.00 | 36.00 | 47.00 | 633.00 | 194.00 | 240.00 | 1.02K | 769.60 | 288.80 |
| Weighted Avg Shares Out | 27.69M | 27.68M | 27.63M | 27.61M | 27.61M | 27.58M | 27.65M | 27.66M | 27.71M | 27.89M | 28.11M | 27.90M | 27.93M | 27.98M | 27.99M | 27.93M | 27.93M | 27.93M |
| Weighted Avg Shares Out (Dil) | 27.69M | 27.68M | 27.63M | 27.62M | 27.61M | 27.58M | 27.65M | 27.67M | 27.77M | 27.89M | 28.11M | 27.90M | 27.93M | 27.98M | 27.99M | 27.93M | 27.93M | 27.93M |
Source: https://incomestatements.info
Category: Stock Reports